Thyroid Hormones Disfunctions in the Metabolic Syndrome Patients

To evaluate thyroid hormone levels in patients who have metabolic syndrome and replacement of the hormones if it is necessary is come into prominence.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Objective: This review is made to investigate thyroid hormone level abnormality frequencies in female metabolic syndrome patients who approached an internal medicine polyclinic.Methods: The review was made prospectively in 161 female patients who approached internal medicine polyclinics between July 2009 and March 2010.Results: While metabolic syndrome patients who had a high level of TSH had a ratio of 13%, the ratio in the control group was determined as 0%.

📊

Key Findings & Data:TSH levels in metabolic syndrome patients were 8.96 times higher than in the control group. fT4 levels were lower in 10% of the metabolic syndrome patients; meanwhile, the ratio of the control group was determined as 0%.Conclusion: TSH levels of metabolic syndrome patients are higher than in normal people.

💡

Conclusion & Impact:To evaluate thyroid hormone levels in patients who have metabolic syndrome and replacement of the hormones if it is necessary is come into prominence.

🔬Design:Review & Systematic Survey

📍Scope:2009 Verileri

⚙️Variables:Domain Parameters

Abstract

Objective: This review is made to investigate thyroid hormone level abnormality frequencies in female metabolic syndrome patients who approached an internal medicine polyclinic.Methods: The review was made prospectively in 161 female patients who approached internal medicine polyclinics between July 2009 and March 2010.Results: While metabolic syndrome patients who had a high level of TSH had a ratio of 13%, the ratio in the control group was determined as 0%. TSH levels in metabolic syndrome patients were 8.96 times higher than in the control group. fT4 levels were lower in 10% of the metabolic syndrome patients; meanwhile, the ratio of the control group was determined as 0%.Conclusion: TSH levels of metabolic syndrome patients are higher than in normal people. To evaluate thyroid hormone levels in patients who have metabolic syndrome and replacement of the hormones if it is necessary is come into prominence.

Özet

Amaç: Bu çalışma, dahiliye polikliniğine başvuran metabolik sendromu olan kadın hastalarda tiroid hormonu fonksiyonu bozukluğunun sıklığını araştırmak üzere yapıldı.Yöntemler: Çalışma, dahiliye polikliniğine Temmuz 2009-Mart 2010 tarihleri arasında başvuran 161 kadın hasta ile prospektif olarak yapıldı. Hastaların 100 tanesi metabolik sendromlu olup, 61 tanesi kontrol grubundaydı.Bulgular: Metabolik sendromlu hastalarda tiroid stimülan hormon (TSH) değeri yüksek olanların oranı %13 iken, bu oran kontrol grubunda %0 olarak saptandı. Metabolik sendromlu hastalarda TSH yüksekliği kontrol grubuna göre 8,96 kat artmış bulundu. FT4 değeri ise metabolik sendromlu hastaların %10'nunda düşük bulunurken, kontrol grubunda bu oran %0 olarak saptandı.Sonuç: Metabolik sendromlu hastalarda TSH değeri normal şahıslara göre daha yüksek saptanmıştır. Metabolik sendrom olduğu bilinen hastalarda tiroid hormon düzeylerinin de beraberinde değerlendirilmesi ve gerekirse hormon tedavisine başlamak önem kazanmaktadır.

🔖

Cite This Article

YÜCEL, H., ÇELEBİ, A., AVLAĞI, G. K., BÖYÜK, B. İ., GÜRLER, M., ATALAY, H., YALÇIN, B., ALTAY, M., DEĞİRMENCİOĞLU, Ş., ATEŞ, M., EKİZOĞLU, İ. (2014). Thyroid Hormones Disfunctions in the Metabolic Syndrome Patients. JAREM, Cilt: 4 - Sayı: 3, 102–107. https://ajindex.com/articles/210969

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (16)

Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988
[CrossRef] 2. Lönn L, Stenlöf K, Ottoson M, Lindoors AK, Myström E, Sjösström L. Body weight and body composition changes after treatment of hypothyroidism, Journal of Clinical Endocrinology and Metabolism 1998
[CrossRef] 3. Kllein I. Thyroid hormone and high blood pressure. In
Laragh JH, Brenner BM. Kaplan NM, editors. Endocrine mechasnism in hyper tension, 2nd ed. New York: Raven Pres
p.61-80. 4. McDermott MT. Overview of the clinical manifestations of hypothyroidism. In: Braverman LE, Utiger RD, editors. The throid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott Williams & Wilkins
p. 569-75. 5. Morkin E, Flink IL, Goldman S. Biochemical and physiologic effects of thyroid hormone on cardiac performance. Prog Cardiovace Dis 1983
[CrossRef] 6. Karakurt F, Çarkoğlu A, Köroğlu M, Us B, Kasapoğlu B. Tiroid fonksiyonları obezite için bir risk faktörü müdür? Yeni Tıp Dergisi 2009
Onat A, Sansoy V. Halkımızda koroner hastalığın baş suçlusu metabolik sendrom
sıklığı, unsurları koroner risk ile ilişkisi ve yüksek risk kriterleri.Türk Kardioloji Derneği 2003
Grundy SM. Metabolic syndrome: connecting and reconcoling cardiovasculer and diabetes world. J Am Coll Cardiol 2006
[CrossRef] 9. Meigs JB. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome ? A syndrome at all? Factor analysis revals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000
[CrossRef] 10. Friserd M, Raussin E. Energy metabolism and oxidative stres. Endocrine 2006
[CrossRef] 11. Ginsberg HN, Stablenhoef AF. The metabolic syndrome: targeting dyslipidemia to reduce coronary risk. J Cardiovasc Risk 2003
[CrossRef] 12. Asman G, Schulte H. The Prospective Cardiovasculer Hunster (PROCAM) study: prevalance of hyperlipidemia in persons with hypertansion and/or diabetes mellitus and relationship to coronary heart disease. Am Heart J 1998
[CrossRef] 13. Onat A, Sansoy V. Halkımızda koroner hastalığın baş suçlusu metabolik sendrom: sıklığı, unsurları, koroner risk ile ilişkisi ve yüksek risk kriterleri.Türk Kardioloji Derneği 2002
Onat A, Şenocak M, Örnek E, Gözükara Y, Şurdum-Avcı G, Karaaslan Y, et al. Türkiye'de erişkinlerde kalp hastalığı risk faktörler sağlığ